Reducing cost or at least slowing the annual increase in the cost of medical care is the objective. How this objective is achieved is where the conflict arises.
Archive | October, 2012
In 2009 I wrote a blog, “Retailer Will Pump You Up With Undeclared Steroids.” In this blog, I referenced a study that claimed 25% of all supplements on the market had undeclared substances in them. Unfortunately, for the dietary supplement industry, I believe the latest inspection reports from the FDA may be more damaging. According […]
A report by Marsh states that the U.S. construction industry should expect rate increases of up to 15% in the commercial General Liability market, due to years of soft market conditions. “This comes against the backdrop of medical cost inflation and changes to some state statutes that have extended coverage beyond the insurer’s originally intended […]